Nav: Home

Opioid crisis leads to rise in viable hearts and lungs for those awaiting transplants

May 16, 2018

Last year, a record number of heart transplants were performed in the U.S., but analyses of the data show a dark reason behind this good news: A sharp rise in organ donations is largely driven by the U.S. drug-abuse epidemic. A new study published in The New England Journal of Medicine by investigators from Brigham and Women's Hospital and University of Utah, examines survival outcomes for patients who have received organs from donors who died of drug intoxication. The team reports no significant difference in survival outcomes among patients who received heart and lung transplants from donors who died of drug intoxication, despite these organs being especially sensitive to restrictions in blood supply.

The study also compares donations in the U.S. and Europe. The team saw a jump in the number of organ donors in the U.S. who had died from intoxication - from 59 in the year 2000 to 1,029 in 2016. Over the same span of time, there was no significant change in the number of organ donor deaths from intoxication in Europe.

"We wanted to understand the impact of the drug abuse epidemic on the most vulnerable segments of organ transplants, which include heart and lung organs," said Mandeep R. Mehra, MD, FACC, FESC, FHFSA, FRCP, executive director of the Center for Advanced Heart Disease and medical director of the Heart & Vascular Center at BWH. "Importantly, we were curious to understand if the drug-abuse epidemic is affecting organ donations globally or if this effect is restricted to the United States. We were surprised to find that this is a U.S. issue and not at all seen in the European transplant experience."

Survival rates one year after heart or lung transplantation were similar for recipients who received organs from donors who died from drug intoxication and for those who received organs from donors who died of other causes.

"It's important to remember that while more people are receiving the gift of life, other lives are being lost," said Mehra. "Instead of scientific advancements driving an increase in the pool of available organs, this increase is driven by a crisis, and we cannot rely on this as a source indefinitely. As efforts in health policy to overcome this crisis take root, the transplant community must turn to sustainable ways to increase organ donor recovery."

Investigators at BWH and elsewhere are currently exploring ways to recover organs from current donors considered less suitable. Some of the novel sources being considered are high-risk organs from donors infected with treatable diseases such as hepatitis C or those from donors who experienced cardiac death.
-end-
Paper cited: Mehra, Mandeep et al. "The Drug-Intoxication Epidemic and Solid-Organ Transplantation" NEJM DOI: 10.1056/ NEJMc1802706

Brigham and Women's Hospital

Related Lung Transplantation Articles:

New lung 'organoids' in a dish mimic features of full-size lung
New lung 'organoids' -- tiny 3-D structures that mimic features of a full-sized lung -- have been created from human pluripotent stem cells by researchers at Columbia University Medical Center (CUMC).
Lung ultrasound can help doctors see other diseases that mask as lethal clots in lung
Lung ultrasound can show alternative diagnoses and should be considered when evaluating patients with suspected pulmonary embolism.
Gene delivery to the lung can treat broad range of diseases within and beyond the lung
Targeting therapeutic genes to the lungs offers the potential to manage serious lung diseases that do not respond to other forms of treatment and to use the lungs as metabolic factories to produce therapeutic proteins for treating systemic diseases.
High levels of estrogen in lung tissue related to lung cancer in postmenopausal women
Researchers from Kumamoto University, Japan have found that postmenopausal women with multicentric adenocarcinoma of the lung have a higher concentration of estrogen in non-cancerous areas of the peripheral lung than similar women diagnosed with single tumor lung cancer.
These days fecal transplantation is no joke
Fecal transplants are increasingly being used to treat certain human illnesses and there has been a dramatic increase in animal experiments involving fecal material.
UPMC researchers shine light on common heart complication after lung transplantation
Cardiac arrhythmia is a common complication following lung transplantation, and one that has a significant negative impact on long-term patient survival.
Loyola surgeon is editor of definitive textbook on lung transplantation
Loyola University Medical Center thoracic surgeon Wickii Vigneswaran, MD, is chief editor of the definitive new textbook, 'Lung Transplantation: Principles and Practice.'
Transplantation and cell therapy
Key leaders in the field of cellular therapy will highlight new applications to potentially cure patients with blood diseases and infections on the occasion of the 5th Cell Therapy Day.
Elsevier announces the launch of Transplantation Reports
Elsevier, a world-leading provider of scientific, technical, and medical information products and services today announces the launch of Transplantation Reports, a new online-only open access journal covering all areas of transplantation.
Lung cancer clinical trial finds lung function without additional imaging
A newly NIH funded clinical trial by University of Colorado Cancer Center investigators and collaborators is evaluating a new method for pinpointing and sparing healthy lung tissue during lung cancer radiotherapy.

Related Lung Transplantation Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Setbacks
Failure can feel lonely and final. But can we learn from failure, even reframe it, to feel more like a temporary setback? This hour, TED speakers on changing a crushing defeat into a stepping stone. Guests include entrepreneur Leticia Gasca, psychology professor Alison Ledgerwood, astronomer Phil Plait, former professional athlete Charly Haversat, and UPS training manager Jon Bowers.
Now Playing: Science for the People

#524 The Human Network
What does a network of humans look like and how does it work? How does information spread? How do decisions and opinions spread? What gets distorted as it moves through the network and why? This week we dig into the ins and outs of human networks with Matthew Jackson, Professor of Economics at Stanford University and author of the book "The Human Network: How Your Social Position Determines Your Power, Beliefs, and Behaviours".